drugset / Trial / NCT02918188

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

NCT02918188

Phase 2 Recruiting 21 enrolled Navy General Hospital, Beijing
NaSingle-groupOpen-labelTreatment

Summary

This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.

Timeline

Start
2016-01
Primary completion
2026-01
Completion
2031-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrogen Unknown 500 ml Oral